Cargando…
Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study
OBJECTIVE: Coronavirus disease 2019 (COVID-19) is a major challenge facing the world. Certain guidelines issued by National Health Commission of the People's Repubilic of China recommend intravenous immunoglobulin (IVIG) for adjuvant treatment of COVID-19. However, there is a lack of clinical e...
Autores principales: | Hou, Xiao, Tian, Li, Zhou, Lei, Jia, Xinhua, Kong, Li, Xue, Yitao, Hao, Hao, Meng, Xianqing, Zhang, Feihu, Dong, Xiaobin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139546/ https://www.ncbi.nlm.nih.gov/pubmed/34020680 http://dx.doi.org/10.1186/s12985-021-01575-3 |
Ejemplares similares
-
Adjuvant intravenous immunoglobulin administration on postoperative critically ill patients with secondary peritonitis: a retrospective study
por: Choi, Young Un, et al.
Publicado: (2023) -
Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study
por: Liu, Jiao, et al.
Publicado: (2021) -
Erratum to "Adjuvant intravenous immunoglobulin administration on postoperative critically ill patients with secondary peritonitis: a retrospective study"
por: Choi, Young Un, et al.
Publicado: (2023) -
Intravenous Immunoglobulin-Associated Severe Hemolytic Anemia
por: KC, Ojbindra, et al.
Publicado: (2023) -
Intravenous Immunoglobulin (IVIg) Utilization in Immune Thrombocytopenia (ITP): A Multi-Center, Retrospective Review
por: Hsia, Cyrus C., et al.
Publicado: (2015)